Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $183.23M in the twelve months ending March 31, 2024, with 28.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $41.37M with 33.95% year-over-year growth. In the year 2023, Travere Therapeutics had annual revenue of $145.24M with 32.69% growth.

• Revenue (ttm): $183.23M
• Revenue Growth: +28.61%
• P/S Ratio: 4.07
• Revenue / Employee: $482,171
• Employees: 380
• Market Cap: 746.06M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	145.24M	35.78M	32.69%
Dec 31, 2022	109.46M	-22.38M	-16.97%
Dec 31, 2021	131.84M	-66.49M	-33.52%
Dec 31, 2020	198.32M	22.98M	13.11%
Dec 31, 2019	175.34M	11.09M	6.75%
Dec 31, 2018	164.25M	9.31M	6.01%
Dec 31, 2017	154.94M	21.35M	15.98%
Dec 31, 2016	133.59M	33.70M	33.74%
Dec 31, 2015	99.89M	71.69M	254.19%
Dec 31, 2014	28.20M	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.